AGM/EGMJun 26, 2026, 04:17 PM
PDS Biotech to Double Authorized Shares to 300M at Annual Meeting
AI Summary
PDS Biotechnology Corporation announced its Annual Meeting of Stockholders to be held virtually on August 10, 2026. Key proposals for shareholder vote include the election of two Class B directors, an amendment to increase the number of authorized common stock from 150,000,000 to 300,000,000 shares, and the ratification of KPMG LLP as the independent registered public accounting firm for fiscal year 2026. Additionally, shareholders will cast a non-binding advisory vote on the compensation of the company's named executive officers. The record date for voting is June 15, 2026.
Key Highlights
- Shareholders to vote on increasing authorized common stock from 150,000,000 to 300,000,000 shares.
- Proposals include the election of Kamil Ali-Jackson, J.D. and Ilian Iliev, Ph.D. as Class B directors.
- Shareholders will ratify KPMG LLP as the independent auditor for fiscal year 2026.
- An advisory vote will be held on the compensation of named executive officers.
- The Annual Meeting will be held virtually on August 10, 2026, at 8 a.m. Eastern Time.
- The record date for voting is June 15, 2026.
- There were 55,815,653 shares of common stock outstanding and entitled to vote on the record date.
Price Impact
More from PDSB